Project Details
Project Description
The PrEPX Study enrolled over 5,000 participants between 2016 and 2018 in Victoria, South Australia and Tasmania. Participants were at risk of HIV infections and received daily tenofovir+ emtricitabine for HIV pre-exposure prophylaxis (PrEP). PrEP can reduce the risk of HIV transmission by 99% when taken with high adherence. The primary aim of the study was to reduce the incidence of new HIV infections at a population level. The study was enriched with a number of secondary endpoints.
A/Prof Wright received AUD$2,600,000 in total to fund the PrEPX study from The Victorian, South Australian and Tasmanian Departments of Health, from Alfred Health and from the Victorian AIDS Council. The funding was awarded to the Department of Infectious Diseases, Monash Central Clinical School.
A/Prof Wright received AUD$2,600,000 in total to fund the PrEPX study from The Victorian, South Australian and Tasmanian Departments of Health, from Alfred Health and from the Victorian AIDS Council. The funding was awarded to the Department of Infectious Diseases, Monash Central Clinical School.
| Short title | PrEPX |
|---|---|
| Status | Finished |
| Effective start/end date | 26/07/16 → 31/12/19 |
Research output
- 4 Article
-
Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection
Traeger, M. W., Cornelisse, V. J., Asselin, J., Price, B., Roth, N. J., Willcox, J., Tee, B. K., Fairley, C. K., Chang, C. C., Armishaw, J., Vujovic, O., Penn, M., Cundill, P., Forgan-Smith, G., Gall, J., Pickett, C., Lal, L., Mak, A., Spelman, T. D. & Nguyen, L. & 12 others, , 9 Apr 2019, In: JAMA. 321, 14, p. 1380-1390 11 p.Research output: Contribution to journal › Article › Research › peer-review
340 Link opens in a new tab Citations (Scopus) -
Interest in Switching to On-Demand HIV Pre-Exposure Prophylaxis (PrEP) among Australian Users of Daily PrEP: An Online Survey
Cornelisse, V. J., Lal, L., Price, B., Ryan, K. E., Bell, C., Owen, L. & Wright, E. J., 1 Jul 2019, In: Open Forum Infectious Diseases. 6, 7, 5 p., ofz287.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile34 Link opens in a new tab Citations (Scopus) -
Evaluation of PrEP eligibility criteria using sexually transmissible infections as HIV risk markers at enrolment in PrEPX, a large Australian HIV pre-exposure prophylaxis trial
Cornelisse, V., Fairley, C., Stoove, M., Asselin, J., Chow, E. P. F., Price, B., Roth, N. J., Willcox, J., Penn, M., Tee, B., Chang, C. C., Armishaw, J., Fogan-Smith, G., Wright, E. J. & for the PrEPX Study Team, 28 Nov 2018, In: Clinical Infectious Diseases. 67, 12, p. 1847-1852 6 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access12 Link opens in a new tab Citations (Scopus)